VISAKHAPATNAM: The Visakhapatnam Special Economic Zone (VSEZ) on Friday granted approvals to Hetero Biopharma in JadcherlaSEZ in Telangana to manufacture various vital drugs related to Covid, such as Tocilizumab, Tenecteplase, Denosumab for testing purposes.
Likewise, Divis Lab in Yadadri-Bhongir will manufacture 100 MT of API Molnufiravir per year, which is also a Covid drug. Unit 2 of Hetero Biopharma in Jadcherla SEZ will also produce 120 million doses of Sputnik V Covid vaccine per year.
The pharmaceutical company will also export vaccines worth Rs 1,150 crore when approved. In the meantime, these vaccines will be used in the country.
According to VSEZ Development Commissioner A Rama Mohana Reddy, Shilpa Medicare will manufacture 26,664 vials of Amphotericin-B Liposome Injection (50 mg / vial), as it is in high demand for the treatment of black fungus patients.
Stating that VSEZ has become a pharmaceutical hub in the country, he said, the high standard pharmaceutical SEZs located in Atchutapuram, Parawada, Pydibheemavaram, Bheemili, Nakkapalli, Jadcherla have renowned and successfully operating pharmaceutical companies like Dr Reddy’s, Divis, Laurus Labs, Biocon, Pfizer, Lee Pharma, Cornelius, Gland Pharma, Shilpa Medicare, Sanofi, Mylan, Aurobindo, Hetero etc.
He also added that last year the pharmaceutical units of VSEZ exported products worth Rs 20,500 crore and they recorded a growth of 40%.
“Also this year, in just 2 months, pharmaceuticals worth Rs 4,240 crore were exported,” he said. Besides the units and developers, JDC, DDC and Telangana customs officials under VSEZ, the meeting brought together all senior officials from DGFT, Revenue, Excise, Customs, Drugs Controller and TS IT.
Speaking to the media, Reddy said that during the current year despite the lockdown, VSEZ achieved an export of Rs 20,173 crore through June 14, which is 21% more than last year in during the same period. Reddy also appreciated all units and developers, especially the pharmaceutical sector for their contribution, which saw merchandise growing 31 percent and services 17 percent this year.
Products worth Rs 4,240 crore exported in 2 months
VSEZ Development Commissioner A Rama Mohana Reddy said VSEZ pharmaceutical units were exporting products worth Rs 20,500 crore and had grown by 40%. “This year too, in just 2 months, pharmaceutical products worth Rs 4,240 crore were exported.”